Mast Therapeutics Inc (NYSE MKT LLC:MSTX)

Wednesday’s trading has closed, but MSTX is being traded in the after-hours session. After-Hours quote »
0.49
Delayed Data
As of 4:01pm ET
 0.00 / 0.00%
Today’s Change
0.40
Today|||52-Week Range
0.69
-12.50%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$79.9M

Company Description

Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. Its lead product MST-188 has cytoprotective and hemorheologic properties and inhibits inflammatory processes and thrombosis. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA.

Contact Information

Mast Therapeutics, Inc.
3611 Valley Centre Drive
San Diego California 92130
P:(858) 552-0866
Investor Relations:
18585520866303

Employees

Shareholders

Other institutional12.28%
Mutual fund holders10.36%
Individual stakeholders0.29%

Top Executives

Brian M. CulleyChief Executive Officer & Director
Brandi L. RobertsChief Financial Officer, CAO & Senior VP
Edwin L. ParsleyChief Medical Officer & Senior Vice President
Robert Martin EmanueleSenior Vice President-Development
Gregory D. GorgasSenior Vice President-Commercial

To view my watchlist

Not a member yet?

Sign up now for a free account